<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Clinical characteristics concerning psychiatric disorders at baseline</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Patients 
     <italic>(N = 144)</italic>
    </th>
    <th>Group A</th>
    <th>Group B</th>
    <th>
     <bold>
      <italic>p</italic>
     </bold>-value
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>
     <bold>Types of psychiatric illnesses,</bold>
     <bold>
      <italic>n</italic>
     </bold>
     <bold>(%)</bold>
    </td>
    <td/>
    <td>
     <italic>101 (70.1)</italic>
    </td>
    <td>
     <italic>43 (29.9%)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Anxiety disorders</italic>
     <sup>a</sup>
    </td>
    <td/>
    <td>
     <italic>48 (33.3%)</italic>
    </td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Mood disorders</italic>
     <sup>b</sup>
    </td>
    <td/>
    <td>
     <italic>53 (36.8%)</italic>
    </td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Psychotic disorder</italic>
    </td>
    <td/>
    <td/>
    <td>
     <italic>43 (29.9%)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <bold>Duration psychiatric illness, years (range)</bold>
    </td>
    <td>9 (6–13)</td>
    <td>8 (6.5–12.5)</td>
    <td>12 (8–15.5)</td>
    <td>
     <bold>0.011</bold>
    </td>
   </tr>
   <tr>
    <td>
     <bold>Suicide attempted,</bold>
     <bold>
      <italic>n</italic>
     </bold>
     <bold>(%)</bold>
    </td>
    <td>5 (3.5%)</td>
    <td>2 (2%)</td>
    <td>3 (7%)</td>
    <td>0.157</td>
   </tr>
   <tr>
    <td>
     <bold>Psychiatric treatment modification before DAA treatment,</bold>
     <bold>
      <italic>n</italic>
     </bold>
     <bold>(%)</bold>
    </td>
    <td>20 (13.9%)</td>
    <td>11 (10.9%)</td>
    <td>9 (21%)</td>
    <td>0.121</td>
   </tr>
   <tr>
    <td>
     <bold>Opioid substitution treatment,</bold>
     <bold>
      <italic>n</italic>
     </bold>
     <bold>(%)</bold>
    </td>
    <td>12 (8.3%)</td>
    <td>2 (2%)</td>
    <td>10 (23.3%)</td>
    <td>
     <bold>&lt; 0.001</bold>
    </td>
   </tr>
   <tr>
    <td>
     <italic>Methadone</italic>
    </td>
    <td>11 (7.6%)</td>
    <td>1 (1%)</td>
    <td>10 (23.3%)</td>
    <td>
     <bold>&lt; 0.001</bold>
    </td>
   </tr>
   <tr>
    <td>
     <italic>Buprenorphine</italic>
    </td>
    <td>1 (0.7%)</td>
    <td>1 (1%)</td>
    <td>0</td>
    <td>1.000</td>
   </tr>
   <tr>
    <td>
     <bold>Referred alcohol consumption,</bold>
     <bold>
      <italic>n</italic>
     </bold>
     <bold>(%)</bold>
    </td>
    <td>5 (3.5%)</td>
    <td>4 (4%)</td>
    <td>1 (2.3%)</td>
    <td>1.000</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>Legend:</italic>
   <sup>a</sup>-social phobia-posttraumatic stress disorder-panic disorder-generalized anxiety disorder;
  </p>
  <p>
   <sup>b</sup>-current major depressive episode-current manic episode-current hypomanic episode;
  </p>
 </table-wrap-foot>
</table-wrap>
